文献速递食管胃疾病与幽门螺杆菌消化内镜消化道肿瘤与早癌

贲门失弛缓症与食管鳞癌及腺癌风险的多国研究

Achalasia and Risk of Esophageal Squamous Cell Carcinoma and Adenocarcinoma in a Multinational Study.
PubMed 文献 · Gastroenterology · 2026-04-20

该研究基于5个北欧国家1987至2023年的人群病例对照数据,纳入35,604例食管癌病例及355,869例匹配对照,发现贲门失弛缓症与食管鳞癌风险显著独立相关(OR 9.46),与食管腺癌的关联较弱且经胃食管反流病调整后减弱(OR 1.44)。

要点

  • 贲门失弛缓症患者食管鳞癌风险约为无该病者的9.46倍,且独立于吸烟和饮酒。
  • 贲门失弛缓症与食管腺癌的关联在调整胃食管反流病后明显减弱。
  • 接受肌切开或扩张治疗的贲门失弛缓症患者鳞癌关联更强(OR 16.33)。

核心结论

  • 贲门失弛缓症与食管鳞癌呈强且独立的关联,与食管腺癌的关联较弱且可能主要由胃食管反流病解释。

研究设计与样本

  • 研究为基于5个北欧国家1987至2023年人群的病例对照研究,纳入35,604例食管癌病例和355,869例按年龄、性别、日历年和国家匹配的背景人群对照。

主要发现

  • 贲门失弛缓症与食管鳞癌风险显著升高相关(OR 9.46;95% CI 7.07-12.65)。
  • 贲门失弛缓症与食管腺癌呈中度关联(OR 3.05;95% CI 2.14-4.35),调整GERD后减弱(OR 1.44;95% CI 0.99-2.09)。
  • 接受肌切开或扩张治疗的贲门失弛缓症与食管鳞癌关联更强(OR 16.33;95% CI 11.26-23.67),与食管腺癌调整GERD后无显著关联(OR 1.32;95% CI 0.76-2.30)。

临床怎么用

  • 对贲门失弛缓症患者应关注食管鳞癌的长期监测,尤其是有肌切开或扩张治疗史者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Achalasia appears to increase the risk of esophageal squamous cell carcinoma, but existing evidence relies on small studies that did not adjust for this cancer's main risk factors (ie, smoking and alcohol overconsumption). Whether achalasia increases the risk of esophageal adenocarcinoma, whose main risk factor is gastroesophageal reflux disease (GERD), is even more uncertain. This study aimed to clarify these associations. METHODS: A population-based case-control study was conducted in 5 Nordic countries from 1987 to 2023. Esophageal cancer cases (n = 35,604) were matched to 10 times as many background population controls by age, sex, calendar year, and country (n = 355,869). Conditional logistic regression provided odds ratios (ORs) with 95% confidence intervals (CIs), adjusted for smoking and alcohol, and additionally for GERD in a mechanistic model. All variables came from national health data registries. RESULTS: Achalasia was present in 137 cases (96 squamous cell carcinomas and 41 adenocarcinomas) and 230 controls (99 squamous cell carcinomas and 131 adenocarcinomas). Achalasia was associated with a strongly increased risk of esophageal squamous cell carcinoma (OR, 9.46; 95% CI, 7.07-12.65). A moderate association was found for esophageal adenocarcinoma (OR, 3.05; 95% CI, 2.14-4.35), which attenuated after adjustment for GERD (OR, 1.44; 95% CI, 0.99-2.09). Achalasia treated with myotomy or dilation was associated with an even stronger association with esophageal squamous cell carcinoma (OR, 16.33; 95% CI, 11.26-23.67), but not with esophageal adenocarcinoma after adjustment for GERD (OR, 1.32; 95% CI, 0.76-2.30). CONCLUSIONS: Achalasia appears strongly and independently associated with esophageal squamous cell carcinoma. The association with esophageal adenocarcinoma is less strong and seems to be largely explained by GERD.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Leijonmarck W, Santoni G, Holmberg D, et al. Achalasia and Risk of Esophageal Squamous Cell Carcinoma and Adenocarcinoma in a Multinational Study. Gastroenterology. 2026. PMID: 42019768. doi:10.1053/j.gastro.2026.03.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。